The arrival of innovative obesity therapies has sparked significant attention and debate. These compounds, often targeting hormones pathways, seem to provide meaningful weight loss for patients battling with obesity. However, questions remain regarding their future impact, likely side effects, and accessibility for a broad group of patients. While